- $111.01m
- $119.24m
- $66.59m
- 93
- 79
- 36
- 79
Annual income statement for Pro-Dex, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
R2021 June 30th | R2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 38 | 42 | 46.1 | 53.8 | 66.6 |
| Cost of Revenue | |||||
| Gross Profit | 13.6 | 13.1 | 12.7 | 14.6 | 19.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 33.5 | 36.9 | 40.3 | 46.7 | 55.9 |
| Operating Profit | 4.53 | 5.12 | 5.76 | 7.17 | 10.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 7.62 | 5.69 | 9.43 | 2.63 | 12.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.17 | 4.57 | 7.07 | 2.13 | 8.98 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.17 | 4.57 | 7.07 | 2.13 | 8.98 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6.17 | 4.57 | 7.07 | 2.13 | 8.98 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.57 | 1.22 | 1.95 | 0.596 | 2.67 |